Every state, kept current
The Rates plan
$29/mo7-day free trialThis page shows one representative rate per state for J9213. Full schedules include every locality, modifier, and age-band variant.
- Every code on all 51 published schedules
- Full-schedule CSV export and state network lists
- Email alerts when a state changes its rates
$29/mo after the trial. Cancel anytime.
Publishing states
12
Median % of Medicare
--
Rate range
$29.65 - $407.24
J9213 rates in every publishing state
| State | Medicaid rate | % of Medicare | Prior auth | Vintage |
|---|---|---|---|---|
| Arkansas | $32.24 | -- | -- | 2026 |
| District of Columbia | $29.65 | -- | Not required | 2016 |
| Iowa | $35.14 | -- | -- | 2020 |
| Idaho | $40.13 | -- | Not required | 2025 |
| Kansas | $43.01 | -- | -- | 2009 |
| Maine | $407.24 | -- | -- | 2026 |
| New Jersey | $40.53 | -- | Not required | 2026 |
| New Mexico | $42.96 | -- | -- | 2025 |
| Rhode Island | $57.56 | -- | -- | 2026 |
| Virginia | $40.53 | -- | -- | 2008 |
| Washington | $40.53 | -- | -- | 2026 |
| Wisconsin | $40.53 | -- | -- | 2008 |
Published Medicaid fee-for-service schedule amounts, not a coverage or eligibility guarantee. Managed-care plan rates can differ. Where no prior-authorization flag is shown, the state does not publish one. Rows marked * are representative published variants or methodology-derived rates. "--" in the prior-auth column means the state publishes no PA flag.
Related drugs codes
- J0013 - Esketamine, nasal spray, 1 mg
- J0120 - Injection, tetracycline, up to 250 mg
- J0121 - Injection, omadacycline, 1 mg
- J0122 - Injection, eravacycline, 1 mg
- J0129 - Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)
- J0130 - Injection abciximab, 10 mg
- J0131 - Injection, acetaminophen, not otherwise specified,10 mg
- J0132 - Injection, acetylcysteine, 100 mg
All 198 codes from J9000 to J9601 or every drugs code by number.
Frequently asked questions
How much does Medicaid pay for J9213?
12 state Medicaid programs publish a fee-for-service rate for J9213 (injection, interferon, alfa-2a, recombinant, 3 million units), ranging from $29.65 in District of Columbia to $407.24 in Maine. The full table on this page lists every publishing state's current rate.
Which state pays the most for J9213?
Maine publishes the highest Medicaid rate for J9213 at $407.24. District of Columbia publishes the lowest at $29.65.
Does J9213 require prior authorization under Medicaid?
No publishing state flags J9213 with a prior-authorization indicator on its fee schedule. Absence of a flag means the state publishes none, not that PA is never required - confirm through the state's provider manual.